AECL pension contributions safe, says AECL’s Quinn Publish Date: 03-NOV-2014 08:35 AM A recent letter to the editor, “AECL Chalk River to be forced to walk off job,” (The Hill Times, Oct. 27, p. 8) contained inaccuracies with respect to employee pensions. I want to emphasize that contributions to the Public Service Pension Plan (PSPP) will not be lost. On Nov. 3, AECL will launch a wholly-owned subsidiary named Canadian Nuclear Laboratories (CNL). AECL employees who will be reorganized into the new subsidiary will continue to participate in the PSPP until CNL becomes a private-sector-managed organization.
Launch of Canadian Nuclear Laboratories Publish Date: 30-OCT-2014 09:05 AM On November 3, Atomic Energy of Canada Limited (AECL), will proudly launch a wholly-owned subsidiary named Canadian Nuclear Laboratories (CNL). This is a major milestone in the restructuring of AECL that will ultimately revitalize Canada’s premier nuclear science and technology organization.
AECL to GoCo: Do it right Publish Date: 17-SEP-2014 08:38 AM The government wants to offload the running of AECL’s Nuclear Laboratories, which employ over 3,400 highly skilled employees across Canada (a majority of them at Chalk River), under a different privatization model described as government-owned, contractor-operated (GoCo) management. So far, there’s little evidence the government has learned much if anything from past experience.
Nuclear innovation benefits Canada Publish Date: 21-AUG-2014 03:19 PM The Sylvia Fedoruk Canadian Centre for Nuclear Innovation will soon be operating a new multipurpose cyclotron at the University of Saskatchewan. This cyclotron facility, one of the most advanced in the country, will be a source of medical isotopes and a centre of excellence for applying those isotopes for research into the diagnosis and treatment of conditions like heart disease, Parkinson's and Alzheimer's, multiple sclerosis and cancer.
Isotope maker Nordion sale faces final hurdle with shareholders Publish Date: 25-MAY-2014 01:51 PM Nordion Inc., the Canadian medical isotope provider with a long and storied history, is about to become part of an American company. Created almost seven decades ago as the radium sales department of Eldorado Mining and Refining Ltd., Nordion took over the sale of radioisotopes from the nuclear research facility at Chalk River, Ont., before becoming part of Atomic Energy of Canada Ltd. in the 1950s. It was part of MDS Health Group for two decades before being spun off as a standalone public company in 2010. And if shareholders give their okay at a meeting in Ottawa on Tuesday, Nordion will move into its next phase – as the subsidiary of a U.S. company based in Chicago.
CFIA Consultations and Canadian Food Safety (PDF)
Publish Date: 19-DEC-2014 02:44 AM
As part of the 2014 CFIA Consultations, the Professional Institute of The Public Service of Canada (PIPSC) has submitted a detailed analysis of each of the following proposals:
Scientists Rally in Support of Federal Research
Publish Date: 27-NOV-2014 11:16 AM
On the morning of October 22, researchers and science staff from Natural Resources Canada, Agriculture & Agri-food Canada and the Department of National Defence demonstrated in Québec city at the entrance of Université Laval in support of research in the federal government.
The Canada First Research Excellence Fund seems to be the Harper government’s response to fierce criticism about its science policies. It was announced with much fanfare last week (although it had appeared in the spring budget) by Prime Minister Stephen Harper as an unprecedented investment to strengthen Canada’s position in the world of science. But it came on the heels of an uproar in the scientific community over the imminent shuttering of a world-class science facility at the University of Ottawa, highlighting precisely what many critics believe is wrong with the Conservatives’ approach to science.
Irrités par les interventions du gouvernement Harper, les scientifiques fédéraux ont concocté un répulsif inusité: des clauses à insérer dans leur convention collective. Reste à voir si le remède sera homologué.